MYC and acute myeloid leukemia: Furthermore, METTL14 is highly expressed in acute myelocytic leukaemia (AML) and can promote the occurrence of AML by inhibiting the degradation of MYB and MYC mRNA, promoting its translation and maintaining the self-renewal of leukaemia stem cells (19).